DiaMedica Therapeutics Inc. (DMAC) › RevenueDiaMedica Therapeutics Inc. (DMAC) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2018$500.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share